These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


7783 related items for PubMed ID: 1450992

  • 1. [Targeting of tumor cells by low density lipoproteins: principle and use of ellipticin derivatives].
    Favre G.
    C R Seances Soc Biol Fil; 1992; 186(1-2):73-87. PubMed ID: 1450992
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Vectorization of antineoplastic drugs by low density lipoproteins: incorporation of acyl celiptium and metabolism of complexes in the cellular receptor of human fibroblasts].
    Samadi-Baboli M, Favre G, Soula G.
    Bull Cancer; 1989; 76(8):853-7. PubMed ID: 2620112
    [No Abstract] [Full Text] [Related]

  • 7. Stable incorporation of a lipophilic daunorubicin prodrug into apolipoprotein E-exposing liposomes induces uptake of prodrug via low-density lipoprotein receptor in vivo.
    Versluis AJ, Rump ET, Rensen PC, van Berkel TJ, Bijsterbosch MK.
    J Pharmacol Exp Ther; 1999 Apr; 289(1):1-7. PubMed ID: 10086980
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Low density lipoprotein and liposome mediated uptake and cytotoxic effect of N4-octadecyl-1-beta-D-arabinofuranosylcytosine in Daudi lymphoma cells.
    Koller-Lucae SK, Schott H, Schwendener RA.
    Br J Cancer; 1999 Jul; 80(10):1542-9. PubMed ID: 10408395
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Preparation of low density lipoprotein-9-methoxy-ellipticin complex and its cytotoxic effect against L1210 and P 388 leukemic cells in vitro.
    Samadi-Baboli M, Favre G, Blancy E, Soula G.
    Eur J Cancer Clin Oncol; 1989 Feb; 25(2):233-41. PubMed ID: 2702978
    [Abstract] [Full Text] [Related]

  • 16. Potential role of the low-density lipoprotein receptor family as mediators of cellular drug uptake.
    Chung NS, Wasan KM.
    Adv Drug Deliv Rev; 2004 May 07; 56(9):1315-34. PubMed ID: 15109771
    [Abstract] [Full Text] [Related]

  • 17. Cytotoxic effect of a lipophilic alkylating agent after incorporation into low density lipoprotein or emulsions: studies in human leukemic cells.
    Masquelier M, Lundberg B, Peterson C, Vitols S.
    Leuk Res; 2006 Feb 07; 30(2):136-44. PubMed ID: 16085310
    [Abstract] [Full Text] [Related]

  • 18. [The cytotoxic effect of a low density lipoprotein delivered aclarubicin on leukemia cells].
    Li W, Xi S, Zhang M.
    Zhonghua Xue Ye Xue Za Zhi; 2001 Dec 07; 22(12):636-8. PubMed ID: 16200711
    [Abstract] [Full Text] [Related]

  • 19. Preparation of anti-HIV-low-density lipoprotein complexes for delivery of anti-HIV drugs via the low-density lipoprotein pathways.
    Sqalli-Houssaini H, Pierlot C, Kusnierz JP, Parmentier B, Martin-Nizard F, Lestavel-Delattre S, Tartar A, Fruchart JC, Sergheraert C, Duriez P.
    Biotechnol Ther; 1994 Dec 07; 5(1-2):69-85. PubMed ID: 7703834
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 390.